Table 3 Hematopoietic reconstitution in NSG mice
From: Endothelial and hematopoietic hPSCs differentiation via a hematoendothelial progenitor
Samples | Human CD34 | hPSC-EB-CD144+ | PBS | ||||||
|---|---|---|---|---|---|---|---|---|---|
#1 | #2 | #1 | #2 | #3 | #4 | #5 | #1 | #2 | |
%hCD45 in the PB | 9% | 1% | 1.5% | 0.6% | 0.5% | 0.9% | 3.6% | 0% | 0% |
%hCD45 in the BM | Â | Â | Â | Â | Â | Â | Â | Â | Â |
 RF | 10% | 9% | 0.1% | 0.3% | 0.1% | 0.1% | 0.6% | 0% | 0% |
 LF | 5% | 1% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Human DNA fold change | Â | Â | Â | Â | Â | Â | Â | Â | Â |
 RF | 1 | 0.662 | 0.007 | 0.210 | 0.013 | 0.0004 | 0.051 | ND | ND |
 LF | 0.175 | 0.008 | ND | ND | 0.0002 | ND | ND | ND | ND |